Contract #,Client,Brand,Vehicle,Placement ID,Placement Description,Buy Component Type,Data Type,Frequency,Contracted Metric,Notes
20308-9-134638,Eli Lilly & Company,Breast Cancer Medical Affairs,Matrix Medical Communications - Webinar,300976,399572|BRECMA|EBC|MMC|Matrix Medical Communications - Webinar|2025 Rollover OnDemand Enduring Landing Page 12 months|MS|WA|E|NA|TL|SPT|NA|NA|CON|NA|None|NA|NA|AV|NM|NA|NA,Display- Non Targeted,AGG,Weekly,N/A,Lilly EBC Webinar Landing Page Views
20988-9-140346,AstraZeneca Oncology,Imfinzi GI MATTERHORN HCP,Matrix Medical Communications - Video Conference Coverage,314514,424965|IMFGIMAT|GC|MMC|MMCVCC|2026 asco gi video conference coverage|DB|EM|E|NA|TL|NA|NA|NA|AW|ENL|NA|NA|NA|NA|MAT|NA|NA,e-Newsletters- Targeted/Programmatic,PLD & AGG,Weekly,Opens_unique,ASCO GI Video Conference Coverage eNLs
20988-9-140346,AstraZeneca Oncology,Imfinzi GI MATTERHORN HCP,Matrix Medical Communications - Video Conference Coverage,314517,424969|IMFGIMAT|GC|MMC|MMCVCC|2026 asco gi value add enl|DB|EM|E|NA|TL|NA|NA|NA|AW|ENL|NA|NA|NA|AV|MAT|NA|NA,e-Newsletters- Targeted/Programmatic,PLD & AGG,Weekly,Opens_unique,ASCO GI Video Conference Coverage Wrap-up eNL
21230-9-141645,Eli Lilly & Company,Inluriyo,Matrix Medical Communications - Custom Email,317742,INLUR|BC|MMC|MMCCE|Custom Email|EM|EM|E|NA|TL|NA|NA|NA|AW|NA|None|NA|NA|NA|SOA|NA|NA_ID~434608,Email,PLD & AGG,Weekly,Impressions,Iluriyo Custom Emails
21165-9-142110,Eli Lilly & Company,Preclin.AD Medical Affairs,Matrix Medical Communications - Custom Email,318897,AG~CMI_BD~HCP_MB~Neuroscience_SB~PCADMA_IN~ALZ_SNM~MMC_SVH~MMCCE_CH~EM_COC~NA_CDL~OTHER_PB~NA_OB~AW_S1~DIR_DT~XD_DP~Direct_TG~TL_TG2~TL_DM~None_GE~NTL_D1~NA_IT~NA_CIT~E_CEM~NA_A1~NA_A2~NA_A3~NA_FM~DB_MR~CPE_AS~NA_VF~NA_MA~GM_FF3~Pre Survey eNL_ID~441277,e-Newsletters- Targeted/Programmatic,PLD & AGG,Weekly,Opens_unique,PCAD Pre-survey eNL
21165-9-142110,Eli Lilly & Company,Preclin.AD Medical Affairs,Matrix Medical Communications - Custom Email,318899,AG~CMI_BD~HCP_MB~Neuroscience_SB~PCADMA_IN~ALZ_SNM~MMC_SVH~MMCCE_CH~EM_COC~NA_CDL~OTHER_PB~NA_OB~AW_S1~DIR_DT~XD_DP~Direct_TG~TL_TG2~TL_DM~None_GE~NTL_D1~NA_IT~NA_CIT~E_CEM~NA_A1~NA_A2~NA_A3~NA_FM~DB_MR~CPE_AS~NA_VF~NA_MA~GM_FF3~Post Survey eNL_ID~441276,e-Newsletters- Targeted/Programmatic,PLD & AGG,Weekly,Opens_unique,PCAD Post-survey eNL
21165-9-142110,Eli Lilly & Company,Preclin.AD Medical Affairs,Matrix Medical Communications - Custom Email,318903,AG~CMI_BD~HCP_MB~Neuroscience_SB~PCADMA_IN~ALZ_SNM~MMC_SVH~MMCCE_CH~EM_COC~NA_CDL~OTHER_PB~NA_OB~AW_S1~DIR_DT~XD_DP~Direct_TG~TL_TG2~TL_DM~None_GE~NTL_D1~NA_IT~NA_CIT~E_CEM~NA_A1~NA_A2~NA_A3~NA_FM~DB_MR~CPE_AS~NA_VF~NA_MA~GM_FF3~Unique episode eNLs_ID~441278,e-Newsletters- Targeted/Programmatic,PLD & AGG,Weekly,Asset_start_interactions,New Podcast eNLs
21165-9-142110,Eli Lilly & Company,Preclin.AD Medical Affairs,Matrix Medical Communications - Custom Email,318907,AG~CMI_BD~HCP_MB~Neuroscience_SB~PCADMA_IN~ALZ_SNM~MMC_SVH~MMCCE_CH~EM_COC~NA_CDL~OTHER_PB~NA_OB~AW_S1~DIR_DT~XD_DP~Direct_TG~TL_TG2~TL_DM~None_GE~NTL_D1~NA_IT~NA_CIT~E_CEM~NA_A1~NA_A2~NA_A3~NA_FM~DB_MR~CPE_AS~NA_VF~NA_MA~GM_FF3~Wrap Up eNL AV_ID~441283,e-Newsletters- Targeted/Programmatic,PLD & AGG,Weekly,Opens_unique,PCAD Wrap-up eNL
21165-9-142110,Eli Lilly & Company,Preclin.AD Medical Affairs,Matrix Medical Communications - Custom Email,321639,AG~CMI_BD~HCP_MB~Neuroscience_SB~PCADMA_IN~ALZ_SNM~MMC_SVH~MMCAAP_CH~WA_COC~NA_CDL~NA_PB~NA_OB~AW_S1~DIR_DT~NA_DP~Direct_TG~TL_TG2~NA_DM~None_GE~NTL_D1~NA_IT~NA_CIT~E_CEM~SOA_A1~NA_A2~NA_A3~NA_FM~DB_MR~CPE_AS~NA_VF~NA_MA~GM_FF3~MMLP_ID~446927,e-Newsletters- Targeted/Programmatic,PLD & AGG,Monthly,Page_view,PCAD Podcast Landing Page Views
21682-9-142978,"AbbVie, Inc",Rinvoq AD,Matrix Medical Communications - Expert Perspectives Video Program,320695,442694|RINAD|AD|MMC|MMCEPVP|Expert Perspectives in AD Landing Page|DB|WA|E|NA|TL|NA|NA|NA|AW|SPS|NA|NA|NA|AV|BRD|CS|NA,Display- Non Targeted,AGG,Monthly,Impressions,EP in Atopic Dermatitis Landing Page Views
21682-9-142978,"AbbVie, Inc",Rinvoq AD,Matrix Medical Communications - Expert Perspectives Video Program,320697,442700|RINAD|AD|MMC|MMCEPVP|Expert Perspectives in AD eNL|DB|EM|E|NA|TL|NA|NA|NA|AW|ENL|NA|NA|NA|NA|BRD|ENL|NA,e-Newsletters- Targeted/Programmatic,PLD & AGG,Weekly,Opens_unique,EP in Atopic Dermatitis eNLs
21682-9-142978,"AbbVie, Inc",Rinvoq AD,Matrix Medical Communications - Expert Perspectives Video Program,320699,442803|RINAD|AD|MMC|MMCVCC|DEF Video Conference Coverage Landing Page|DB|WA|E|NA|TL|NA|NA|NA|AW|SPS|NA|NA|NA|AV|BRD|TLD|NA,Display- Non Targeted,AGG,Monthly,Impressions,DEF Video Conference Coverage Landing Page Views
21682-9-142978,"AbbVie, Inc",Rinvoq AD,Matrix Medical Communications - Expert Perspectives Video Program,320701,442805|RINAD|AD|MMC|MMCVCC|DEF Video Conference Coverage eNLs|DB|EM|N|NA|TL|NA|NA|NA|AW|ENL|NA|NA|NA|NA|BRD|ENL|NA,e-Newsletters- Targeted/Programmatic,PLD & AGG,Weekly,Opens_unique,DEF Video Conference Coverage eNLs
21307-9-141056,Genentech USA,Vabysmo PAN,Matrix Medical Communications - Custom Email,316254,431510|VABPAN|PAN|MMC|MMCCE|Custom Email|EM|EM|E|NA|TL|NA|NA|NA|AW|NA|None|NA|NA|NA|NA|NA|NA,Email,PLD & AGG,Weekly,Opens_unique,Vabysmo Custom Emails
21100-9-141809,Eli Lilly & Company,Verzenio - Breast,Matrix Medical Communications - Custom Email,318132,VERBRE|EBC|MMC|MMCCE|UNBRANDED Custom Email |EM|EM|E|NA|TL|NA|NA|NA|AW|NA|None|NA|NA|NA|SOA|NA|NA_ID~434774,Email,PLD & AGG,Weekly,Opens_unique,Verzenio Custom Emails
21100-9-141809,Eli Lilly & Company,Verzenio - Breast,Clinical Updates in Breast Cancer,318135,VERBRE|EBC|MMC|CUBC|Target List Clinical Updates eNewsletter|DB|EM|E|NA|TL|NA|NA|NA|AW|ENL|None|NA|NA|AV|NM|NA|NA_ID~434808,Email,PLD & AGG,Weekly,Opens_unique,Clinical Updates in Breast Cancer
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
